Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken-ichiro Inoue

Showing results (21-30 of 149) with videos related to

Pageof 15
Sort By:
Chest|July 13, 2002
Peroxisome proliferator-activated receptor-gamma expression in lungKen-ichiro Inoue, Yutaka Kawahito, Hajime Sano
International Immunopharmacology|August 31, 2010
Comprehensive analysis of elastase-induced pulmonary emphysema in mice: effects of ambient existing particulate mattersKen-ichiro Inoue, Eiko Koike, Hirohisa Takano
The Journal of Allergy and Clinical Immunology|March 4, 2008
Pin1 blockade in asthma by naphthoquinone?Ken-Ichiro Inoue, Hirohisa Takano, Yoshito Kumagai
Thrombosis and Haemostasis|May 2, 2008
Protective role of metallothionein in coagulatory disturbance accompanied by acute liver injury induced by LPS/D-GalNKen-ichiro Inoue, Hirohisa Takano, Masahiko Satoh
Asian Cardiovascular & Thoracic Annals|June 9, 2017
A case of supernumerary intrathoracic ribMasaki Ikeda, Ken-Ichiro Inoue, Hideki Kusagaya
American Journal of Respiratory and Critical Care Medicine|September 21, 2020
Role of IL-6 in Severe InflammationKen-Ichiro Inoue, Tomoya Sagawa, Hirohisa Takano
Journal of Clinical Biochemistry and Nutrition|January 12, 2008
Components of diesel exhaust particles diversely enhance a variety of respiratory diseases related to infection or allergy: extracted organic chemicals and the residual particles after extraction differently affect respiratory diseasesHirohisa Takano, Rie Yanagisawa, Ken-Ichiro Inoue
Arerugi = [Allergy]|January 31, 2015
[Progress in the study concerning adverse effects of particulate matters on allergy]Michitaka Tanaka, Ken-Ichiro Inoue, Hirohisa Takano
Critical Care (London, England)|August 20, 2020
Preventing the clinical manifestations and disease progression of coronavirus disease using clinically proven protease inhibitorsTomoya Sagawa, Ken-Ichiro Inoue, Hirohisa Takano
Lancet (London, England)|March 7, 2003
Comments on the common coldKen-ichiro Inoue, Hirohisa Takano, Toshikazu Yoshikawa
Pageof 15

Showing results (21-30 of 149) with videos related to

Sort By:
Pageof 15
Chest|July 13, 2002
Peroxisome proliferator-activated receptor-gamma expression in lungKen-ichiro Inoue, Yutaka Kawahito, Hajime Sano
International Immunopharmacology|August 31, 2010
Comprehensive analysis of elastase-induced pulmonary emphysema in mice: effects of ambient existing particulate mattersKen-ichiro Inoue, Eiko Koike, Hirohisa Takano
The Journal of Allergy and Clinical Immunology|March 4, 2008
Pin1 blockade in asthma by naphthoquinone?Ken-Ichiro Inoue, Hirohisa Takano, Yoshito Kumagai
Thrombosis and Haemostasis|May 2, 2008
Protective role of metallothionein in coagulatory disturbance accompanied by acute liver injury induced by LPS/D-GalNKen-ichiro Inoue, Hirohisa Takano, Masahiko Satoh
Asian Cardiovascular & Thoracic Annals|June 9, 2017
A case of supernumerary intrathoracic ribMasaki Ikeda, Ken-Ichiro Inoue, Hideki Kusagaya
American Journal of Respiratory and Critical Care Medicine|September 21, 2020
Role of IL-6 in Severe InflammationKen-Ichiro Inoue, Tomoya Sagawa, Hirohisa Takano
Journal of Clinical Biochemistry and Nutrition|January 12, 2008
Components of diesel exhaust particles diversely enhance a variety of respiratory diseases related to infection or allergy: extracted organic chemicals and the residual particles after extraction differently affect respiratory diseasesHirohisa Takano, Rie Yanagisawa, Ken-Ichiro Inoue
Arerugi = [Allergy]|January 31, 2015
[Progress in the study concerning adverse effects of particulate matters on allergy]Michitaka Tanaka, Ken-Ichiro Inoue, Hirohisa Takano
Critical Care (London, England)|August 20, 2020
Preventing the clinical manifestations and disease progression of coronavirus disease using clinically proven protease inhibitorsTomoya Sagawa, Ken-Ichiro Inoue, Hirohisa Takano
Lancet (London, England)|March 7, 2003
Comments on the common coldKen-ichiro Inoue, Hirohisa Takano, Toshikazu Yoshikawa
Pageof 15